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Equine infectious anemia virus (EIAV) envelope variation produces newly dominant quasispecies with each sequential disease cycle; new
populations arise, and previous plasma quasispecies, including the original inoculum, become undetectable. The question remains whether these
ancestral variants exist in tissue reservoirs or if the immune system eliminates quasispecies from persistent infections. To examine this, an EIAV
long-term inapparent carrier was immune suppressed with dexamethasone. Immune suppression resulted in increased plasma viral loads by
approximately 104 fold. Characterization of pre- and post-immune suppression populations demonstrated continual envelope evolution and
revealed novel quasispecies distinct from defined populations from previous disease stages. Analysis of the tissue and plasma populations post-
immune suppression indicated the original infectious inoculum and early populations were undetectable. Therefore, the host immune system
apparently eliminated a diverse array of antigenic variants, but viral persistence was maintained by relentless evolution of new envelope
populations from tissue reservoirs in response to ongoing immune pressures.
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Natural and experimental infection of equids with equine
infectious anemia virus (EIAV) results in a rapid and dynamic
disease process that differs markedly from the slowly
progressive degenerative diseases associated with other lenti-
viral infections including HIV-1 infection of humans. EIA
disease is characterized by three distinct stages: acute, chronic,
and long-term asymptomatic (Clements et al., 1994; Montelaro
et al., 1993; Oaks et al., 1998). Acute disease is typically
observed within 3 to 4 weeks post-infection and is associated
with high levels of viremia and clinical signs of disease
including fever, diarrhea, lethargy, edema, thrombocytopenia,
and anemia. Chronic EIA, characterized by repeated cycles of
disease and associated waves of viremia, lasts approximately0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Nationale Ve´te´rinaire de Lyon, IFR 128.8 to 12 months post-infection. EIA disease cycles occur at
irregular intervals, separated by weeks or months, with an
average of six to eight disease episodes within the first year
post-infection. At this time, most infected horses become
asymptomatic for EIA indefinitely, presumably due to the
development of enduring protective host immunity. These
inapparent carriers, however, remain infected for life with the
maintenance of markedly different subclinical levels of steady
state virus replication (Harrold et al., 2000; Leroux et al.,
2001). Thus, EIAV offers a unique model for characterizing
natural immunologic control of lentivirus replication and
disease and for elucidating the nature and role of viral variation
in persistence and pathogenesis.
Studies of EIAV variation during persistent infection in
experimentally infected equids have clearly identified dynamic
changes in envelope sequences that alter viral antigenic
properties, evidently as a result of immune selection (Leroux
et al., 1997b, 2001; Lichtenstein et al., 1996). The predominant
site of EIAV variation during persistent infection is the gp90
surface envelope glycoprotein, and the pattern of gp906) 340 – 353
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define distinct conserved and variable protein domains (Leroux
et al., 1997b) as observed with other animal and human
lentiviruses (Greene et al., 1993; Leroux et al., 1997a;
Simmonds et al., 1990; Starcich et al., 1986; Suarez and
Whetstone, 1995). These patterns of EIAV envelope variation
and defined conserved and variable envelope domains have
been confirmed by others (Zheng et al., 1997a, 1997b).
Variation of the EIAV envelope gene has therefore served as
a distinct marker for analysis of viral population evolution.
Previous studies from our laboratory have demonstrated that
the viral populations associated with the cyclic disease
episodes of chronic EIA are distinct genomic and antigenic
variants (Leroux et al., 1997b, 2001; Payne et al., 1987).
Detailed molecular characterization of EIAVenvelope variation
during sequential disease cycles in experimentally infected
ponies revealed the presence of distinct EIAVenvelope variants
with each wave of viremia (Leroux et al., 1997b). Examination
of inapparent stage viral populations from the plasma of the
same ponies indicated that evolution of the viral quasispecies is
continuous, even with relatively low levels of detectable virus
replication in the periphery or tissues (Leroux et al., 2001).
These results suggest that, even in the absence of detectable
plasma virus, viral populations, most likely in tissue reservoirs,
continue to replicate and evolve, seeding the plasma with new
viral quasispecies.
Tissue reservoirs of lentiviral populations have been
designated not only as active sites of replication, but also as
reservoirs for latent viral genomes (Blankson et al., 2002; Chun
et al., 1997). The development of viral reservoirs contributes to
the extraordinary level of persistence and in some instances
pathogenesis associated with lentiviral infections (Finzi et al.,
1999; Persaud et al., 2003). Tissue reservoirs can harbor a
stable pool of viral populations undergoing cryptic low levels
of replication or contain a latent viral population such as
observed with HIV-1 found in resting memory CD4+ T cells
(Han et al., 2004; Lassen et al., 2004). In both cases, tissue
reservoirs theoretically can provide a stable archive of
quasispecies reflecting the entire history of the viral infection.
Whether early or initial viral quasispecies are completely
eliminated from the archive of lentiviral reservoir populations
has not been established.
An interesting observation from our previous studies of
chronic and inapparent stage viral isolate evolution is that there
appeared to be a consistent loss of ancestor populations. The
departure of ancestral populations was concurrent with the
appearance of new Env quasispecies, suggesting effective
immune suppression or elimination of the prior actively
replicating quasispecies. These snapshots of viral populations
were all taken from isolates circulating in the plasma. Thus, it
is possible that infecting and transient quasispecies may
continue to exist in tissue reservoirs as latent or low replicating
provirus in infected monocytes and macrophage. Severe
immune suppression of EIAV-infected equids through admin-
istration of the glucocorticoid dexamethasone has been
previously demonstrated to suppress the host immune system
and induce the recrudescence of viral replication and clinicalEIA (Craigo et al., 2002; Kono et al., 1976; Tumas et al.,
1994). Removal of the immune control of the latent EIAV
reservoirs theoretically frees viral replication that can enable
detection of not only minor populations, but also of the
archived ancestral populations. Therefore, to determine wheth-
er early viral populations remained within the infected host, we
immune suppressed a long-term EIAV inapparent carrier (30
months) from which plasma viral evolution had been charac-
terized in detail (Leroux et al., 1997b, 2001). Viral populations
detected and analyzed before and during immune suppression,
in both tissues and plasma, for the first time indicated an
effective elimination of ancestor viral quasispecies from
infected equids, suggesting that the host immune system is
able to effectively eliminate persistent infection by a range of
type-specific quasispecies.
Results
Clinical and virologic profile during EIAVPV infection and
subsequent immune suppression
Previous studies from our laboratory extensively character-
ized envelope variation in long-term inapparent carrier ponies
experimentally infected with our pathogenic strain, EIAVPV
(Leroux et al., 1997b, 2001). The four ponies were each
classified as either ‘‘progressor’’ or ‘‘nonprogressor’’ based on
the disease process experienced by each individual animal
(Leroux et al., 2001). Pony #567, a progressor pony, experienced
six febrile episodes accompanied by high viral loads (106–109
RNA copies/ml plasma) over the initial 750-day observation
period (Fig. 1). Following the sixth fever, pony #567 entered the
inapparent stage of EIA and was asymptomatic throughout the
rest of the 3.5-year observation period but maintained low levels
of viral replication which averaged approximately 103 RNA
copies/ml plasma (Fig. 1). Pony #567 viral envelope character-
ization exhibited elevated levels of gp90 variation (amino acid
divergence = 7.44 T 0.48%) and produced the highest number
of evolving viral populations (32 detected populations from
inoculum to final inapparent analysis) as compared to the
other experimentally infected ponies (Leroux et al., 2001).
While the viral quasispecies in pony #567 continued to
evolve new variant species, viral quasispecies which had
appeared in the early stages of disease, including the original
infectious inoculum, were no longer detectable in plasma.
To explore all the viral populations persisting in pony #567,
we chemically immune suppressed this pony for a 14-day
period to release immunologic restraint of all existing viral
quasispecies and allow free replication of virus from tissue
reservoirs. Prior to immune suppression, pony #567 demon-
strated no clinical signs of EIA disease and low to moderate
viral loads which averaged approximately 103 RNA copies/ml
plasma. Immune suppression was carried out through daily
I.M. injections of 0.11 mg/kg of dexamethasone (1224 D.P.I. to
1237 D.P.I.). Pony #567 was monitored daily for adverse
affects of the drug. Recrudescence of viral species as well as
disease was contingent on thorough depression of the immune
system. Successful suppression of pony #567 immune system
Fig. 1. Clinical and virological profile of experimentally infected and immune suppressed pony #567. Pony #567 was experimentally infected with 103 TCID50 of the
biological clone EIAVpv. Rectal temperatures (—, right y axis) and platelet counts (----, 1st left y axis) were followed daily for up to 1250 days (x axis) after
inoculation and during immune suppression. Quantitation of the virus load (0, 2nd left y axis) was performed on viral RNA extracted from plasma at periodic time
points throughout the initial infection, fever episodes, and asymptomatic stages and daily during immune suppression observation period. The period of immune
suppression is designated by a shaded box. Febrile episodes were defined by a rectal temperature above 39 -C in conjunction with a reduction in the number of
platelets below 100,000/Al of whole blood and other clinical signs of EIA disease. I, II, III, IV, V, and VI (,) indicate fever episodes.
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hypersensitivity (DTH) analysis and in vitro fluorescence-
activated cell sorting (FACS) analysis of CD4+ and CD8+ cells
(Fig. 2). DTH assays were utilized at multiple time points
throughout the dexamethasone treatment and revealed a marked
decrease in reactivity during drug treatment, the DTH ratio
decreasing from 2.5 prior to treatment to 1.25 on day 11 of
treatment. Further verification of the efficacy of immune
suppression was performed concurrently through FACS staining
of CD4+ and CD8+ PBMC taken from the pony during the
immune suppression regimen (Fig. 2). FACS analysis also
exhibited suppression of the immune system, with CD4+ cells
decreasing from 28% to 9% and CD8+ cells decreasing from
18% to 2%. The results of both the DTH and FACS analysis
clearly indicated successful immune suppression by the end ofFig. 2. Verification of immune suppression via both in vivo and in vitro analyses.
system, a delayed-type hypersensitivity assay was performed as described in Materi
vitro FACS assays (left y axis) as described in Materials and methods to confirm th
----, indicates the end of drug treatment.the 14-day dexamethasone treatment while also demonstrating
quick recovery of the immune system following removal of drug
treatment. The animal developed no clinical signs of EIA during
the extensive 14-day immune suppression period. Platelet levels
showed minor decreases that are commonly observed with
increased viral replication but never dropped to the point of the
thrombocytopenia associated with EIA (Fig. 1). Likewise, the
daily rectal temperature of #567 demonstrated fluctuations,
however, the peaks in temperature never crossed the threshold of
39 -C that is indicative of EIA disease. Viral replication
increased from 103 to 107 RNA copies/ml plasma during
immune suppression, peaking at 107 RNA copies/ml plasma
on day 10 of treatment but returned within 6 days to moderate
levels of 104 RNA copies/ml plasma prior to cessation of
treatment.To measure in vivo the effects of dexamethasone suppression of the immune
als and methods (shaded bars, right y axis). PBMC samples were assayed in in
e effect of the dexamethasone on the immune suppression. g, CD4+; 0, CD8+;
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during immune suppression
Previous studies from our laboratory (Leroux et al., 1997a,
2001; Lichtenstein et al., 1996; Payne et al., 1989) and others
(Zheng et al., 1997a, 1997b) indicate that EIAV envelope
variation during persistent infection is localized to specific
segments of the gp90 surface glycoprotein, with relatively minor
variation observed in the gp45 transmembrane protein. There-
fore, for this study, we focused on the highest region of
variability within the gp90 envelope protein, the third variable
region (V3) through the seventh variable region (V7). Since
there was a 500-day period between the last population analysis
and the start of immune suppression, we initially determined the
EIAV population immediately prior to the immune suppression
(Leroux et al., 2001). EIAV quasispecies were examined
therefore immediately prior to and during the period of immune
suppression. EIAV envelope sequences were determined using
viral RNA recovered from pelleted plasma virus or lymph node
tissue virus prior to (1207 D.P.I.-tissue/1219 D.P.I-plasma) and
during (1234 D.P.I.-plasma/1239 D.P.I.-tissue) immune sup-
pression (referred to as post-immune suppression). A total of 85
clones from the immune suppression period were subjected to
sequence analysis in addition to a combined analysis of 52
additional febrile isolate clones from previous studies for a
combined total of 137 clones analyzed for this population study.
Nature of pony #567 viral quasispecies amino acid sequence
changes
The principal goal of the current study was to examine
whether the initial infecting viral quasispecies or early febrile
virus populations remained in minor populations and/or in tissue
reservoirs after long-term infection. Once nucleotide sequencing
of the V3–V7 regions of the envelope was completed, the
deduced amino acid sequences were visually inspected to
determine the phenotype of the viral quasispecies. The pre-
immune and post-immune suppression viral quasispecies as
compared to EIAVPV and febrile isolates demonstrated a wide
array of alterations including insertions, deletions, and point
mutations of amino acids within the defined gp90 variable
domains of the envelope. As observed in previous studies, the
frequent modification of viral envelope potential N-glycosyla-
tion sites was the most conspicuous change in addition to the
insertion of additional asparagines into the already asparagine-
rich segment of the V7 region (Craigo et al., 2002; Leroux et al.,
1997b, 2001). Ultimately, visual analysis of the viral population
revealed that there was no evidence of EIAVPV or predecessor
quasispecies in any of the populations sampled.
To further characterize the sequences derived during the
immune suppression of pony #567, we compared the temporal
generation of variant amino acid sequences of the emergent
envelope species. Due to the number of sequences involved in
these analyses and the size of the figure they would create, the
actual sequences are not pictured, but the GenBank accession
numbers are provided. To demonstrate the extensive variation
that occurred throughout the current study period in a succinctmanner, we used the level of variation of the highest variable
region of the envelope, the V3 region, as a marker of evolution
(Fig. 3). As previously observed, only two of the sequenced
clones had a V3 sequence identical to EIAVPV by the first fever
(Leroux et al., 2001). At the time of the second fever, all clones
were different from EIAVPV, and none of the species present
during the first fever was apparent. In general, during the
chronic stage of disease, new envelope quasispecies that
typically were present only at a single disease cycle rapidly
replaced the previous population with no further evidence of
the inoculum EIAVPV species. The current observation period
or inapparent phase of disease revealed similar patterns of
evolution. The pre-immune suppression plasma and tissue
populations all demonstrated entirely new V3 regions that do
not indicate overlapping populations even with each other
while sampled only days apart prior to drug treatment. The
post-immune suppression quasispecies reveal for the first time
the apparent reappearance of previously demonstrated signa-
tures in the V3 region. However, the overlap of populations is
with the pre-immune suppression tissue and plasma quasis-
pecies. The fact that the immune suppressive drug treatment
would allow replication of previous viral quasispecies also may
explain the overlapping V3 signatures. While these variants do
appear to reflect the influence of the immune suppression
through recurring species sampling, this time point also
exhibited the emergence of new V3 regions (7 completely
novel species) in the tissue and plasma isolates combined.
Verification of the lymph node tissue as a viral population
reservoir
To confirm that the lymph node was serving as a reservoir of
viral quasispecies, nucleotide sequences were examined. The
analyses were performed solely on the viral isolates from the
tissues and plasma pre- and post-immune suppression. The
sequences spanning the V3 to V7 region of the env gp90 gene
were aligned to the sequence of the original infecting
inoculum, EIAVPV. Our first goal was to verify the lymph
node tissue as a reservoir for viral populations. One would
expect a reservoir population to have higher levels of genetic
diversity as compared to a contemporous or actively replicating
population, while additionally having a lower level of
divergence (Nickle et al., 2003a, 2003b). A contemporous
population would have increased divergence compared to a
reservoir population due to the higher levels of evolution that
occurs through misincorporation of nucleotides by the viral
reverse transcriptase that is associated with active replication
(Bakhanashvili and Hizi, 1993; Preston et al., 1988; Roberts et
al., 1988). Likewise, the diversity within a reservoir popula-
tion, which serially samples and archives viral species over
long periods of time, would be greater than that of a
contemporous population. Therefore, to determine whether
the lymph nodes served as a tissue reservoir of viral
populations, we compared the diversity within the quasispecies
between the lymph node and plasma as well as the divergence
of the lymph node and plasma populations from the inoculating
strain (EIAVPV) (Fig. 4). As summarized in Fig. 4, prior to
Fig. 3. Temporal evolution of gp90 V3 envelope species in pony #567. The figure represents the temporal evolution of the gp90 V3 envelope variable domain of
longitudinal viral populations in pony #567. Each deduced amino acid sequence of gp90 variable regions V3 is depicted as species 1 through 52. The number of
clones containing each specific genetic species is listed in the column after the species symbol, with the total number of clones analyzed indicated at the top of the
figure within that same column. Viral plasma species were determined for the fever episodes (I, II, III, IV, V, and VI) and immune suppression phase of the study.
Each bar represents a species present during the indicated time period (i.e., the inoculum contained a single species). Pre-T, pre-immune suppression tissue; Pre, pre-
immune suppression plasma; PIS-T, post-immune suppression tissue; PIS, post-immune suppression plasma.
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compared to the plasma viral species had a significant
increased level of average population diversity (P < 0.001)while also having a significant decreased level of average
divergence from EIAVPV (P < 0.001). These data are consistent
with the lymph node tissue serving as a reservoir of viral
Fig. 4. Diversity and divergence comparisons between tissue and plasma virus
species prior to and during immune suppression. The median (line) and quartile
(box) differences between the tissue and plasma viral species nucleotide
diversity (A) and divergence (B) are graphed for both the pre-immune
suppression and post-immune suppression populations. Statistical significance
of the differences between the tissue and plasma populations at each time point
for each analyses was performed using nonparametric statistics, the Mann–
Whitney test. *P < 0.0001.
J.K. Craigo et al. / Virology 344 (2006) 340–353 345populations. In contrast, during immune suppressive drug
treatment, population diversity in the lymph node tissue was
decreased as compared to the plasma population. Additionally,
the lymph node species divergence from EIAVPV was slightly
increased as compared to the plasma populations. These
changes in diversity and divergence properties during immune
suppression are inconsistent with the description of a reservoir
sample and suggest that the drug treatment altered the status of
the tissue by allowing free replication within and between
microenvironments.
Determination of free flow of virus between tissues and plasma
during immune suppression
To verify that we had overcome the barrier of tissue
compartmentalization and established a free flow of virus
between all tissue reservoirs and/or compartments, we per-
formed various population analyses including phylogenetics,
compartmentalization, and neutrality tests. If immune suppres-
sive drug treatment allowed unrestricted viral replication and
consequently free gene flow between tissue compartments andplasma, both compartmentalization and selection analyses
should reveal the breakdown of the barriers that normally exist.
The first tool we utilized was phylogenetics (Fig. 5A). A
neighbor-joining phylogenetic tree was constructed utilizing
nucleotide sequences from the plasma and tissue, prior to and
during immune suppression, which had been aligned with and
rooted to EIAVPV. The majority of the quasispecies from both
compartments and time points diverged from the same ancestral
node of EIAVPV (Fig. 5A). The pre-immune suppression plasma
and tissue species appeared compartmentalized, clustering
tightly within their individual microenvironment populations,
supported by high bootstrap values. Furthermore, while the
quasispecies from the two compartments shared common
ancestral nodes, they did not exhibit population intermingling
within individual branches which is suggestive of compartmen-
talization. However, the isolates did not absolutely cluster as
monophyletic groups. The pre-immune suppression tissue
population contained 4 isolates which clustered close to EIAVPV,
indicative of archival sequences from early time points in the
infection. These sequences will be discussed in detail when
considering actual genomic evolution in the next section. In
contrast to the pre-immune quasispecies, the post-immune
suppression plasma and tissue species did not appear to be
compartmentalized, demonstrating a high level of intermingling
at multiple nodes that was indicative of freely merging species or
a lack of compartmentalization.
To confirm the observations from the phylogenetic analysis,
we performed a cladistic method of the Slatkin–Maddison test
by analyzing the data set from both time points and
compartments (Slatkin and Maddison, 1989, 1990). Phyloge-
netic trees were constructed from the pre-immune suppression
and post-immune suppression populations individually prior to
analysis in MacClade. We noted significant restricted gene
flow in the pre-immune suppression populations (P < 0.0001),
observing fewer numbers of steps to reconcile the real tree than
in the random trees. However, during immune suppression,
gene flow appeared unrestricted with the number of steps
required to reconcile the real tree equivalent to that of the
random trees. To support the observed trend of compartmen-
talization of viral quasispecies pre-immune suppression and the
decay of compartmental barriers during immune suppression,
we analyzed the level of gene flow as a measure of genetic
diversity between the tissue and plasma at both time points
(Fig. 5B). At the pre-immune suppression time point, the
average level of gene flow (Nm value) between the tissue and
plasma was 0.72, indicative of significant compartmentaliza-
tion. In contrast, the post-immune suppression tissue and
plasma Nm value was 26, demonstrating a complete lack of
compartmentalization. As a final measure of the removal of
immune restrictions to gene flow, we analyzed for the presence
of positive selection between the tissue and the plasma prior to
and during immune suppression (Fig. 5C). Positive selection
(x = 1.44) was demonstrated prior to immune suppression;
however, selection was neutral to weakly negative (x = 0.97)
during immune suppression. These analyses all suggest that
prior to immune suppression the viral populations in the tissue
and plasma were restricted to their individual microenviron-
Fig. 5. Compartmental analyses of tissue and plasma virus populations prior to and during immune suppression. Compartmental integrity between the plasma and
tissue populations was assessed through three separate analyses: (A) phylogenetics, (B) gene flow calculations, and (C) positive selection determinations. (A) A
phylogenetic tree of aligned plasma and tissue immune suppression nucleotide sequences was constructed by the neighbor-joining method from Jukes Cantor
corrected distances with the optimality criterion set to distance between pre-immune and post-immune suppression populations. The tree was rooted to EIAVPV.
Bootstrap values were determined over 1000 iterations and are indicated at the nodes of the branches. Branch lengths are proportional to the distance existing
between the sequences. Pre, pre-immune suppression; PIS, post-immune suppression. (B) Estimates of gene flow were calculated using codon aligned nucleotide
sequences and determined using software from DnaSP, V4.0 (Rozas et al., 2003; Rozas and Rozas, 1999). Fst and Nm were estimated according to Hudson et al.
(1992). (C) Selection of viral populations was determined through calculations of the rates of synonymous (Ks) and nonsynonymous (Ka) nucleotide substitutions
per site (Nielsen, 2001) of codon aligned nucleotide sequences. The ratio (x) of Ks/Ka was evaluated using the programs available in DnaSP, v.4.0. The average
number of nucleotide substitutions per site was determined between populations (compartments) with Jukes and Cantor corrections. Pre-IS, pre immune suppression;
PIS, post-immune suppression. (—), indicates threshold of positive selection.
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same analyses indicate that the normal barriers which restricted
population replication dynamics were eliminated, and the
quasispecies present in all compartments were estimated to
be free flowing.
Evolutionary analyses of #567 viral quasispecies before and
during immune suppression as compared to the viral species
from disease episodes
To fully characterize the evolution of the viral populations in
pony #567 and to quantify the relatedness of the immune
suppression quasispecies to the preceding viral populations, theentire data set of pre-immune and post-immune suppression
sequences from both compartments were aligned with the
sequences from all 6 fever episodes and EIAVPV (Leroux et al.,
2001). To directly examine evolutionary relationships, we
constructed a neighbor-joining phylogenetic tree with bootstrap
analysis using the aligned hand-edited nucleotide sequences
encompassing the V3 to V7 variable regions of the gp90 env
gene of the entire data set (Fig. 6A). The tree was rooted to the
infecting inoculum, EIAVPV. Examination of the data initially
indicated that the majority of fever viral isolate clones clustered
together separately by time point and that each febrile episode
was followed by the emergence of a novel quasispecies that
reflected mostly new isolates. Previously observed plasma viral
Fig. 6. Population comparisons of pony #567 from all stages of disease, including immune suppression. Evolutionary analyses of the immune suppression isolates
were conducted. (A) A phylogenetic tree of aligned plasma and tissue immune suppression and febrile nucleotide sequences were constructed by the neighbor-
joining method from Jukes Cantor corrected distances with the optimality criterion set to distance. The tree was rooted to EIAVPV. Bootstrap values were determined
over 1000 iterations and are indicated at the nodes of the branches. Branch lengths are proportional to the distance existing between the sequences. (B) Genetic
distances of the nucleotide sequences were calculated using Distance software with Jukes Cantor correction (GCG). The distances of all sequenced clones were
plotted as the divergence from the inoculating strain, EIAVPV. The tissue population is represented by brown circles at the Pre-IS and PIS time points. (C) Genetic
distances of the deduced amino acid sequences were calculated using Distance software with Jukes Cantor correction (GCG). The distances of all clones were plotted
as the divergence from the inoculating strain, EIAVPV. The tissue population is represented by brown circles at the Pre-IS and PIS time points. The days post-
infection for both panels B and C are indicated below the x axis in blue, (—) represents mean divergence; I, II, III, IV, V, VI—fever episodes. Pre, pre-immune
suppression; PIS, post-immune suppression.
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disease cycle, and a new population of viral variants was
associated with the subsequent cycles of disease. The majority
of pre-immune suppression plasma viral isolates followed a
similar pattern, clustering together and at a distance from both
EIAVPV and the febrile species in a manner suggestive of the
emergence of novel quasispecies. This indicated that new viral
species evolved during the inapparent stage of disease with no
evidence of the preceding species. The greater part of the pre-
immune suppression tissue isolates exhibited similar proper-
ties; however, there was less temporal structure as well as a
grouping of archival sequences which clustered with close
proximity to the second fever isolates. The majority of the post-
immune suppression plasma viral variants were intermingledwith the post-immune suppression tissue isolates and demon-
strated similar clustering patterns as compared to the pre-
immune suppression isolates but exhibited less overall distance
from EIAVPV. Additionally, the ‘‘ancestral’’ sequences which
were present in the pre-immune suppression tissue were not
reflected in the plasma or tissue of the viral isolates observed
post-immune suppression. Moreover, the location of the
immune suppression plasma and tissue quasispecies branchings
did not indicate the presence of the original infectious
inoculum or ancestral sequences previous to the third fever.
To specifically examine the degree of genetic distance of the
immune suppression phase populations, we calculated the
divergence of their nucleotide sequences from EIAVPV and
plotted the data as a function of time (Fig. 6B). Divergence
J.K. Craigo et al. / Virology 344 (2006) 340–353348from the inoculating strain increased over time, reaching 4.5%
in the sixth fever population. Pre-immune suppression plasma
isolates demonstrated increased divergence from the febrile
variants at an average level of 5.75%. The pre-immune
suppression tissue population appeared to have a lower
divergence among its viral envelope species, averaging
approximately 4.5% (although this number was lowered by a
few isolates containing values less than 1.0%). Post-immune
suppression plasma variants showed increased divergence as
compared to the febrile isolates, but the average divergence
was lower than that of the pre-immune isolates, averaging
5.25%, likely due to the free replication of minor, previously
dominant species. Post-immune suppression tissue variants
actually exhibited higher divergence, averaging 5.76%, as
compared to the plasma variants which again reflected the free
flow of virus between plasma and tissues during this period.
To determine whether these genotypic differences were also
revealed as protein differences, we calculated the divergence of
the deduced amino acid sequences of all viral quasispecies from
EIAVPV (Fig. 6C). The pattern of increased divergence over
time observed above was equally reflected in the quasispecies
amino acid sequences. The average levels of amino acid
divergence peaked in the pre-immune population at approxi-
mately 20%. The observed pattern of nucleotide and amino acid
divergence among the disease and pre-immune suppression
species indicated that the nucleotide changes were mostly
nonsynonymous. In contrast, the post-immune suppression
tissue variants amino acid sequences did not exhibit the increase
in divergence observed in the nucleotide divergence, likely
reflecting a loss of immune selection during the drug treatment.
To confirm this observation, we examined population neutralityFig. 7. Selection analyses of all populations from pony #567 as compared to EIAVP
rates of synonymous (Ks) and nonsynonymous (Ka) nucleotide substitutions per s
available in DnaSP, v.4.0 and plotted as a function of time. I, II, III, IV, V, and
suppression. (—), indicates threshold of positive selection. (), indicates end of dor selection through calculations of the rates of synonymous
(Ks) and nonsynonymous (Ka) nucleotide substitutions per site
between EIAVPV and all analyzed viral populations. The ratio
(x) of Ka/Ks was plotted as a function of time (Fig. 7). The first
two fever quasispecies revealed ratios <1 reflecting negative
selection or conservation, while all other time points exhibited
ratios >1, indicating positive selection. Regardless of whether
selection was positive or negative, a common pattern emerged
in which immune selection increased over time throughout the
chronic phase of disease, x values increasing from 0.6 at the
first fever to 2.5 during the sixth fever. The quasispecies from
the pre- and post-immune suppression also demonstrated ratios
indicative of positive selection (pre-immune suppression = 1.7,
post-immune suppression = 1.5); however, it is noteworthy to
mention that the level of selection appeared to decrease during
the inapparent stage of disease when viral replication was in a
state of immunological control.
Discussion
EIAV provides a uniquely dynamic model for investigating
the natural immunologic control of lentiviral replication and
disease and for elucidating the nature and role of genomic and
antigenic variation in lentivirus persistence and pathogenesis.
We, as well as others, have previously utilized this model for
comprehensive studies of viral variation during persistent and
inapparent infection. These studies have been limited primarily
to the characterization of plasma virus quasispecies associated
with sequential clinical episodes during chronic disease and
variants that appear during inapparent disease. These analyses
have revealed that a new population of quasispecies emergesV. Population neutrality or selection was determined through calculations of the
ite (Nielsen, 2001). The ratio (x) of Ks/Ka was evaluated using the programs
VI indicate fever episodes. Pre, pre-immune suppression. PIS, post-immune
rug treatment.
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emergence of new populations is the apparent disappearance
of preceding viral populations. We have previously shown that
the initial infecting virus strain disappears in some instances as
early as the second fever episode (within the first 2 months of
infection) (Leroux et al., 2001). In fact, to date, there is no
evidence as to the existence or status of the original virus strain
in long-term lentiviral infections. Therefore, we endeavored
here to ask whether this disappearance of ancestral species was
due to elimination of the preceding quasispecies or to a tight
containment of ancestral populations to tissue reservoirs.
EIAV persists in tissues and cells long after the signs of
disease have subsided. Inapparent carriers of EIAV, as found
with all persistent lentiviral infections, maintain reservoirs of
viral infection for life. It is generally accepted that persistent
viral infections, in contrast to acute viral infections, are lifelong
infections that are never completely cleared by the host immune
system. Long-term persistence in a host for certain viruses relies
on the establishment of a true latency: a reversible, yet non-
productive state of infection that involves the integration of the
viral genome with the host genome and results in restricted gene
expression or viral replication. Lentiviruses replicate continu-
ously, even in the prolonged asymptomatic period for primate
lentiviruses between primary infection and disease (HIV-1) or
for EIAV in particular, during the final inapparent stage of
disease (Leroux et al., 2001). HIV-1 has been demonstrated to
persist in reservoirs consisting of small pools of latently infected
resting memory CD4+ T cells carrying the integrated viral
genome (Blankson et al., 2002; Chun et al., 1997). EIAV,
however, naturally infects cells of the monocyte/macrophage
lineage. Macrophage cells, unlike T cells, do not divide and are
incapable of resuming a ‘‘resting state’’ as observedwith infected
CD4+ T cells. Ultimately, EIAV infection of macrophage
culminates in a lytic infection, and therefore the viral genome
is unlikely to reside in a state of ‘‘true’’ latency within these cells.
Thus, long-term EIAV reservoirs likely exist as stable dynamic
pools of infected cells undergoing low levels of viral replication
in macrophage-rich tissues. The active replicating populations
that have to this date been characterized focus on the ‘‘escape’’
populations that overtly circumvent the immune system well
enough to replicate to levels that induce disease. The populations
we were interested in elucidating were the minor species that
may exist at very low levels, ‘‘hiding’’ from, or resistant to, the
neutralizing antibodies and cellular immune responses elicited to
these predecessor virus strains (Hammond et al., 2000; Howe et
al., 2002; Leroux et al., 1997b). Therefore, we sought to induce
active and increased replication of these species by removing the
controlling factor of the equation, the immune system.
The desire to characterize the entire population present,
minor species as well as dominant species dictated our decision
to not perform limiting dilution for our PCR/cloning protocols
(Rodrigo et al., 2001), while continuing to independently clone
multiple reactions and select a high number of isolates. While
the technique of limiting dilution is a very sound method for
preventing the resampling of isolates, it also favors the cloning
of dominant species, not minor ones which can be lost in the
dilution process. Increasing the lower limit of the number ofPCR reactions to clone as well as the lower limit of isolates to
characterize not only increased our probability of sampling
minor species, but also increased the number of unique clones
we would characterize in terms of resampling (Rodrigo et al.,
2001).
Dexamethasone suppression of the immune system has
previously been demonstrated to suppress the overall immune
system causing a recrudescence of viral replication and EIA
disease in the majority of treated horses (Craigo et al., 2002;
Kono et al., 1976; Tumas et al., 1994). We demonstrated here
that the immune suppression of pony #567 was both successful
and extensive (cf. Fig. 2), although clinical signs of disease did
not accompany the treatment. Examination of the pre-immune
and post-immune suppression viral quasispecies confirms what
we have previously reported that, regardless of the low level of
plasma virus replication, viral evolution is continuous. All of
the pre-immune suppression plasma isolates demonstrated
increased evolution and significant sequence divergence from
the previously characterized febrile viral isolates (cf. Fig. 6B,
6th fever: pre-immune suppression plasma, P = 0.0004). The
tissue reservoir prior to immune suppression did carry 4 isolate
sequences which exhibited very little nucleotide divergence
(less than 1.0%) from EIAVPVand clustered phylogenetically in
close proximity to EIAVPV. While initially these species appear
to indicate the presence of ancestral sequences, the nucleotide
sequences of the 4 species are quite different from those
recorded from the fever episodes. Additionally, upon immune
suppression, these variants apparently disappeared from the
tissue and were also not evident in the post-immune
suppression plasma. This suggests that these strains may
express RNA but not produce replication-competent virus.
Pre-immune suppression tissue variants also revealed divergent
clones which demonstrated a similar level of divergence as
fever five and six isolates. However, inspection of the specific
residues indicated that these isolates were very different in
sequence, even though they purely contained a similar level of
divergence from EIAVPV. Immune suppression induced in-
creased viral replication and the circulation of previously
uncharacterized quasispecies. Variants from this phase demon-
strated a lower level of evolution phylogenetically, and the
quasispecies primarily exhibited decreased divergence as
compared to pre-immune suppression tissue and plasma
isolates. However, as compared to the majority of previously
cataloged species from the fever episodes, these latter species
appeared to be primarily new quasispecies sequences, perhaps
from a time point during the inapparent stage of disease that
was uncharacterized. While pre-immune suppression tissue
isolates and a number of post-immune suppression isolates
indicated the presence of archival species, specific inspection
of the deduced amino acid sequences revealed that all new
populations, pre-immune and post-immune suppression-
derived, were in fact distinct from previous populations. The
few former species observed during immune suppression were
from the pre-immune suppression isolates. The pre-immune
and post-immune suppression variants were sampled approx-
imately 2 weeks apart which may explain their overlapping
V3 signatures.
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suppression revealed mostly nonsynonymous mutations, indic-
ative of ongoing evolution. Furthermore, immune selection
analyses indicated that all populations were under positive
selection after the second fever episode. Interestingly, selection
increased sequentially during the chronic stage of disease
paralleling the increase in the variation of the virus. Selection
slightly declined in the inapparent stage which was likely due to
the decreased interaction of new viral variants with the immune
system. However, the immune suppressive drug treatment likely
accounted for the slight decrease in positive selection between
the pre-immune and immune suppression time points.
The fact that the divergence from EIAVPV was reduced in
the post-immune suppression plasma as compared to the pre-
immune suppression isolates suggests that, while these isolates
were previously uncharacterized, they most likely arose
sometime after the sixth fever episode during the inapparent
stage of disease. Ultimately, all archival sequences failed to
align with the inoculating viral strain or the early species found
in the fever episodes. Therefore, the results of this investigation
indicate that the original infectious viral strain, as well as the
majority of early viral quasispecies, was undetectable or
evidently eliminated by the immune system of the host during
persistent EIAV infection.
Eradication of lentiviral populations is impeded by the
remarkable persistence and pathogenesis associated with these
viral infections. A primary mechanism of lentiviral persistence
is the ability of the viruses to evolve in response to biological
and immunological selective pressures with an extraordinary
array of genetic and antigenic variations. Further means of
persistence also involve the establishment of latent viral
reservoirs. We have for the first time demonstrated that the
equine immune system appears to achieve an effective
elimination of the original infectious virus as well as the early
circulating viral quasispecies that arise through evolution.
Characterization of the EIAV immune suppression period
populations revealed mostly novel quasispecies which were
distinct from previously characterized populations from all
stages of disease. As shown by the EIAV system, immune
control against viral replication can be efficiently established to
successfully restrain emerging viral populations. In EIAV-
infected ponies, host immune responses have matured to the
point that virus variation occurs, but new populations are
unable to escape established immune control. Ultimately, the
host immune system is able to effectively eliminate a diverse
array of antigenic variants; yet, viral persistence is maintained
by the relentless evolution of new envelope populations from
tissue reservoirs in response to ongoing immune pressures.
Materials and methods
Experimental infection, clinical evaluation and sample
collection
An outbred mixed-breed pony (#567) was experimentally
inoculated intravenously with 103 TCID50 of the pathogenic
strain EIAVPV. The clinical and immune responses of thisexperimentally infected pony during chronic and inapparent
infection have been extensively described (Hammond et al.,
1997, 2000; Leroux et al., 1997b, 2001). Rectal temperatures
and clinical status were recorded daily. Clinical EIA episodes
were determined on the basis of rectal temperature and platelet
count in combination with the presence of infectious plasma
virus (Leroux et al., 1997b; Lichtenstein et al., 1996; Montelaro
et al., 1993). Whole blood samples were fractionated for
enumeration of platelets (Unopette microcollection system,
Becton-Dickinson, Rutherford, NJ). Plasma samples were
collected during each disease cycle (defined as rectal temper-
ature >39 -C and platelet number <100,000/Al of whole blood)
and daily during immune suppression and stored at 80 -C
until RNA extraction was performed.
Immune suppression
Procedures for immune suppression of the EIAV-infected
pony were based on protocols implemented previously (Craigo
et al., 2002) and based on published protocols of Kono et al.
(1976) and Tumas et al. (1994). Briefly, dexamethasone
(Phoenix Science, Kansas City, MO) was administered at a
dose of 0.11 mg/kg body weight/day, intramuscularly for 14
days. The pony was monitored daily by complete blood count
(CBC).
Monitoring of immune suppression by DTH and FACS analysis
Skin tests for delayed-type hypersensitivity (Baus et al.,
1996; Hodgin et al., 1978) reactions were performed during the
pre-immune suppression, immune suppression, and post-
immune suppression periods. Skin test sites were prepared by
shaving and cleaning small areas on the neck. The pony was
intradermally administered (at different sites on the neck) both
50 Ag of PHA (Sigma, St. Louis, MO) in 1 ml of saline and 1
ml of saline alone. The net increase in skin thickness was
determined from measurements made with constant tension
calipers 24 h post-injection of antigen. DTH ratios were
calculated as the ratio of antigen (PHA) reaction to control
(saline) reaction. Flow cytometric analyses of equine cell
surface antigens were conducted as previously described
(Hammond et al., 1999). Equine-specific monoclonal antibo-
dies (mAb) used to quantitate levels of specific cell surface
antigens were as follows: CD4 (mAb HB61A; VMRD, Inc.,
Pullman, WA), CD8 (mAb HT14A; VMRD, Inc., Pullman,
WA), and IgG1 (mAb CVS1; Serotec, Raleigh, NC).
RNA Purification and RT-PCR
Viral RNA was extracted from plasma and submandibular
lymph node tissue samples prior to and during immune
suppression as previously described (Craigo et al., 2002;
Harrold et al., 2000; Leroux et al., 1997b, 2001). Reverse
transcription of 2 to 5 Al of purified viral RNA was performed
with the SuperScriptII PreAmplification System (GibcoBRL,
Rockville, MD) as specified by the manufacturer using the
EIAV-specific primer PV12AS (Leroux et al., 1997b). Multiple
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performed as previously described (Leroux et al., 2001) using
the Elongase mix (Gibco BRL, Rockville, MD) and 5 Al of the
cDNA in a final volume of 50 Al.
Quantitation of virus RNA levels in plasma
Semiquantitative measurements of copies of viral genomic
RNA molecules per milliliter of plasma were determined in an
RT-PCR-based assay as described previously (Hammond et al.,
2000).
Cloning and sequencing of RT-PCR products
Several independent RT-PCR products (at least 3 indepen-
dent RT reactions and 6 to 8 independent nested PCR
reactions) were generated from plasma and tissue samples
taken before or during immune suppression, gel-purified using
Qiagen’s Qiaex Gel Purification System (Valencia, CA) and
cloned individually into the pCR2.1-TOPO vector from the
TOPO TA Cloning kit (Invitrogen, Carlsbad, CA). Due to the
highly unstable nature of EIAV env sequences when associated
with high copy plasmids, ligations were transformed in Stbl2
cells (Invitrogen, Carlsbad, CA). Clones were screened for the
proper size insert by PCR using M13 primers from the TOPO
TA Cloning kit. Plasmid DNA was extracted and purified with
a midiprep kit (Qiagen, Valencia, CA). Clones (17–25 from
each sample) were automatically sequenced with the Taq Dye
Deoxy Terminator Cycle Sequencer Kit (Applied Biosystems,
Foster City, CA) using internal EIAV primers (variable region
3 through variable region 7) as previously described (Leroux et
al., 1997b). DNA sequences were resolved with an ABI Prism
373 DNA sequencer (Applied Biosystems, Foster City, CA).
Error rate associated with our nested amplification with the
SuperScript and Elongase polymerases was previously deter-
mined to be 0.015% (3 substitutions per 19,510 bp sequenced)
(Leroux et al., 1997b).
Sequence and population analyses
Sequences were assembled and error checked using Gene-
Jockey II (Biosoft, Cambridge, UK). Nucleotide and deduced
amino acid sequences from each clone were aligned using the
ClustalW multiple sequence alignment program from the GCG
Wisconsin software package (Genetics Computer Group, 2003)
and edited manually and codon aligned when necessary. The
sequences were aligned using the PAM 250 (Dayhoff et al.,
1978) matrix and an open and extend gap penalty cost of 8 and
12 respectively. Genetic algorithm settings were based on the
default parameters. Divergence/diversity analyses were deter-
mined utilizing Jukes Cantor population distance calculations
for nucleotide sequences as executed in the program Distance
from the GCG package of software. Statistical significances of
the mean genetic distances between plasma and tissue samples
were evaluated using a Mann–Whitney two-tailed test, imple-
mented in GraphPad InStat version 3.00 (GraphPad Software,
San Diego California USA, www.graphpad.com).Phylogenetic trees of aligned sequences were constructed by
the neighbor-joining method of Jukes Cantor corrected
distances with the optimality criterion set to distance as
measured in PAUP (Swofford, 2001). Statistical significance
of branchings and clustering was assessed by bootstrap
resampling of 1000 pseudoreplicates on the complete data
set; trees were rooted to the original infectious inoculum,
EIAVPV. The trees were edited for publication using Tree-
view68K version 1.5 (Page, 1996).
Compartmental relationships of the viral samples were
determined using a cladistic method of the Slatkin–Maddison
test (Poss et al., 1998; Slatkin and Maddison, 1989, 1990) by
analyzing the entire data set (prior to and during immune
suppression) from both compartments, tissue and blood. A
UPGMA phylogenetic tree was constructed for sequences from
both the plasma and tissue from both time points analyzed
individually. A multiple state character was created such that
sequences were assigned the same state based on what
compartment they originated from. The number of changes or
evolutionary steps required to reconcile the new individual states
to the phylogenetic true tree was computed usingMacClade 3.06
(Maddison and Maddison, 1992) assuming both soft and hard
polytomies (Beerli et al., 2001; Maddison andMaddison, 1992).
If all sequences in a compartment were monophyletic, the
maximum number of character state changes would equal the
number of compartments minus one. If the sequences were not
compartmentalized, the number of changes would increase.
Statistical significance of the estimated migration events being
significantly smaller than expected by chance in a non-
compartmentalized population was determined by constructing
10,000 random trees made by random joining/splitting of the
phylogenetic tree constructed for each data set. If there was
compartmentalization, the number of steps from the realized tree
would be fewer than the random trees. Compartmentalization
was considered statistically significant if fewer steps were seen
in the true tree than in 95% of the random trees (Beerli et al.,
2001).
Standard population genetic parameters for DNA diversity
were estimated using DnaSP, V4.0 (Rozas et al., 2003; Rozas
and Rozas, 1999). Genetic differentiation between populations
was assessed by estimating Fst, the fraction of nucleotide
diversity as a result of genetic variation between populations
(Hudson et al., 1992). The significance of Fst was determined by
sampling the data 1000 times. The average level of gene flow,
Nm, between the different populations was determined from Fst
(Hudson et al., 1992; Neigel, 1997). Avalue of Nm equal or less
than one indicated significant population subdivision.
Population neutrality or selection was determined through
calculations of the rates of synonymous (Ks) and nonsynon-
ymous (Ka) nucleotide substitutions per site (Nielsen, 2001).
The ratio (x) of Ka/Ks was evaluated using the programs
available in DnaSP, v.4.0 (Rozas et al., 2003; Rozas and Rozas,
1999). The average number of nucleotide substitutions per site
was determined within populations and between populations
(and/or compartments) with Jukes and Cantor correction
(between populations, Dxy, equation 10.20; between species,
K; equation 5.3, but computing as the average of all comparisons
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synonymous and nonsynonymous sites is performed using Nei
and Gojobori equations 1–3 (Nei and Gojobori, 1986). Results
were assessed as follows: negative selection or conservation
(x < 1); neutral evolution (x = 1); positive selection for change
or increased viral replication (x > 1).
Nucleotide sequence accession numbers
The newly analyzed sequences were submitted to GenBank and
have been assigned accession numbers AY858699–AY858784.
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